Gene expression data related to the prognosis of children with neuroblastoma in the TARGET database.

Transcriptomic profiles and matched clinical records were acquired from the Therapeutic Applicable Research to Generate Effective Treatments (TARGET) database. To ensure data quality, we implemented a stringent filtering criterion: transcripts with expression counts below 3 in ≥10% of samples were excluded from subsequent analysis. For survival outcome assessment, univariate Cox proportional hazards regression modeling was performed using the survival package (v3.4.0) in R, incorporating both temporal survival parameters and overall survival (OS) endpoints. Statistical significance was determined at a predefined threshold of P (CSV)